CARL ZEISS MEDITEC ADR 1 (AFXA) — Defensive Interval Ratio
CARL ZEISS MEDITEC ADR 1 (AFXA) has a Defensive Interval Ratio of 140 days as of September 2025. Defensive assets of €209.01 Million (cash €-, short-term investments €-, receivables €209.01 Million) cover 140 days of daily cash needs of €1.49 Million/day. See working capital to net assets of CARL ZEISS MEDITEC ADR 1 to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
CARL ZEISS MEDITEC ADR 1 Defensive Interval Ratio (2022–2025)
This chart shows how CARL ZEISS MEDITEC ADR 1's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of September 2025, the ratio stands at 140 days, meaning defensive assets of €209.01 Million can fund 140 days of operations without new revenue. See net asset quality index of CARL ZEISS MEDITEC ADR 1 to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for CARL ZEISS MEDITEC ADR 1 (2022–2025)
The table below presents the year-by-year Defensive Interval Ratio for CARL ZEISS MEDITEC ADR 1 from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see CARL ZEISS MEDITEC ADR 1 stock valuation.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 140 days | €209.01 Million | €1.49 Million/day | €- | €- | ▲ +6 days |
| 2024 | 134 days | €209.05 Million | €1.56 Million/day | €- | €- | ▲ +6 days |
| 2023 | 128 days | €196.92 Million | €1.54 Million/day | €- | €- | ▼ -6 days |
| 2022 | 134 days | €197.80 Million | €1.48 Million/day | €- | €- | — |